Cargando…
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide. Despite new technologies in diagnosis and treatment, the incidence and mortality of HCC continue rising. And its pathogenesis is still unclear. As a highly cons...
Autores principales: | Liu, Hongying, Wang, Xieqi, Feng, Bing, Tang, Lipeng, Li, Weiping, Zheng, Xirun, Liu, Ying, Peng, Yan, Zheng, Guangjuan, He, Qinglian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006993/ https://www.ncbi.nlm.nih.gov/pubmed/29914442 http://dx.doi.org/10.1186/s12885-018-4458-7 |
Ejemplares similares
-
GOLPH3L antagonizes GOLPH3 to determine Golgi morphology
por: Ng, Michelle M., et al.
Publicado: (2013) -
Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition
por: Wen, Yu, et al.
Publicado: (2019) -
Kun-Dan Decoction Ameliorates Insulin Resistance by Activating AMPK/mTOR-Mediated Autophagy in High-Fat Diet-Fed Rats
por: Su, Zuqing, et al.
Publicado: (2021) -
GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer
por: Scott, Kenneth L., et al.
Publicado: (2009) -
GOLPH3 keeps the Golgi residents at home
por: Lowe, Martin
Publicado: (2021)